Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05256290
What this trial is testing

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Who this might be right for
Non-Small Cell Lung CancerAdvanced Non-Small Cell Squamous Lung CancerMetastatic Lung Non-Small Cell Carcinoma+7 more
Black Diamond Therapeutics, Inc. 200
Early research (Phase 1)Study completedNCT01654497
What this trial is testing

Dexanabinol in Patients With Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari, M.D., Ph.D. 26
Testing effectiveness (Phase 2)Study completedNCT01177397
What this trial is testing

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more
Celgene 226
Very early researchLooking for participantsNCT07485049
What this trial is testing

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Who this might be right for
Glioblastoma (GBM)
Nader Sanai 78
Early research (Phase 1)Looking for participantsNCT05106296
What this trial is testing

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Who this might be right for
EpendymomaMedulloblastomaGlioblastoma+1 more
Theodore S. Johnson 37
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Early research (Phase 1)Study completedNCT00006025
What this trial is testing

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Very early researchLooking for participantsNCT07648823
What this trial is testing

Dosimetry, Safety, and Efficacy Study of [177Lu]Lu-XT771 in Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma (WHO-Grade IV Glioma)Recurrent GlioblastomaGlioblastoma (GBM)+1 more
Beijing Tiantan Hospital 5
Testing effectiveness (Phase 2)UnknownNCT00643825
What this trial is testing

Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients

Who this might be right for
Glioblastoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 64
Testing effectiveness (Phase 2)WithdrawnNCT02348255
What this trial is testing

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Who this might be right for
Adult Brain GlioblastomaRecurrent Adult Brain Neoplasm
University of California, Davis
Early research (Phase 1)UnknownNCT00591058
What this trial is testing

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+2 more
TransMolecular 36
Not applicableStudy completedNCT00897663
What this trial is testing

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 56
Early research (Phase 1)Study completedNCT01234740
What this trial is testing

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+7 more
City of Hope Medical Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00948389
What this trial is testing

Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)

Who this might be right for
Glioblastoma
Bristol-Myers Squibb 28
Testing effectiveness (Phase 2)Study completedNCT00540176
What this trial is testing

The Safety and Efficacy of DCA for the Treatment of Brain Cancer

Who this might be right for
Malignant Gliomas, Glioblastoma Multiforme
University of Alberta 40
Testing effectiveness (Phase 2)Study completedNCT01339052
What this trial is testing

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
L. Nicolas Gonzalez Castro, MD, PhD 65
Early research (Phase 1)Ended earlyNCT00734526
What this trial is testing

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 18
Early research (Phase 1)Study completedNCT01294735
What this trial is testing

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Who this might be right for
Recurrence of Solid TumorGlioblastoma MultiformeMelanoma
Merck Sharp & Dohme LLC 19
Not applicableEnded earlyNCT00473408
What this trial is testing

The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas

Who this might be right for
Anaplastic AstrocytomaGlioblastoma MultiformeTumor Angiogenesis
Haukeland University Hospital 1
Testing effectiveness (Phase 2)Looking for participantsNCT02861898
What this trial is testing

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerBrain Neoplasm+4 more
Northwell Health 33
Next Page